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The structure of 1-[5-(1,3-benzodioxol- 5-yl)-1-oxo-2,4-
pentadienyl]piperidine (Piperine), C17H19O3N, a versatile bioactive 
molecule has been redetermined at 100(2) K by X-ray 
crystallography to explore their potential utilization in inhibition of 
prostaglandin release. The crystal structure is stabilized by weak 
nonclassical intermolecular C-H…O hydrogen bonds and also 
intermolecular C-H…π interactions. The crystallographic 
coordinates of the compound were extrapolated to docking studies 
to elucidate the action of piperine against the enzymes, 
cyclooxygenases (COX-1 and COX-2) involved in biosynthesis of 
prostaglandin release. Using AutoDock suite, piperine was docked 
at the binding site of COX-1 and COX-2 enzyme and a strong 
affinity (-9.06kcal/mol, Ki =227.73nM and -8.77kcal/mol,              
Ki = 375.62nM, respectively) was formed by Hydrogen bonds and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hydrophobic interactions. These results suggest that piperine can be 
a promising lead for the development of COX family inhibitors. 
 
Key words: Prostaglandin, Molecular Docking, X-ray 
crystallography, COX-1, COX-2. 
 
Introduction 
 
Piperine is the principal alkaloid present in the fruits of black pepper 
(Piper nigrum Linn) and long pepper (Piper longum Linn.) belongs 
to the plant family Piperaceae. Administration of piperine has 
proven significant increase in the bioavailability of plasma 
concentrations of rifampin, phenytoin, propranolol and theophylline 
in humans(Bano et al. 1991). 
 
Compound possesses a diverse biological activities including anti-
oxidant, anti-platelet, (Park et al. 2007)anti-inflammatory, analgesic 
(Agus 2005), anti-hyperlipidemic (Jin et al. 2009), antidepressant 
and bioavailability-enhancing activity (Srinivasan 2007). The 
underlying molecular mechanism of such broad range activities of 
piperine is rather poorly understood and previous molecular 
interaction studies have shown only with β-lactoglobulin (Zsila et al. 
2005), human serum albumin(Suresh et al. 2007) and human 
monoamine oxidase (Rahman and Rahmatullah). The piperine 
(figure 1) consists of methylenedioxyphenyl ring, basic piperidine 
moiety attached through a carbonyl amide linkage and side chain 
with conjugated double bond. The crystal structure of piperine was 
redetermined at 100(2) K to accurately determine the position of 
hydrogen atoms along with the associated supramolecular features. 
 
Figure 1: Structure of Piperine 
From the experimental evidence, it was shown that piperine has 
anti-inflammatory properties attributed to inhibition of 
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prostaglandin release(Agus 2005).Under the influence of COX-1, 
prostaglandins maintain the integrity of the gastric mucosa, support 
normal platelet function and control renal blood flow. COX-2 
produces prostaglandins through stimulation and its expression is 
highly restricted; During inflammation COX-2 is dramatically 
upregulated causing pain and fever.(Crofford 1997) Both COX-1 
and COX-2 are the pharmacological targets of aspirin and other 
nonsteroidal anti-inflammatory drugs (NSAIDs), which are utilized 
for the treatment of pain and inflammation(Blobaum and Marnett 
2007). There are clear differences in DNA, mRNA structure and 
function between COX-1 and COX-2, less difference between the 
protein structure and function of these enzymes. The core sequences 
of both enzymes as well as their crystal structures are 60% identical 
but their catalytic regions are widely conserved (Picot 1994). The 
flexibility associated with the side chain of Leu-531 is responsible 
for increasing the volume at the opening of the cyclooxygenase 
channel subsequently allowing COX-2 to oxygenate a wide-ranging 
array of substrates compared to COX-1(Blobaum and Marnett 
2007). 
 
These two COX isoforms differ in many respects. COX-1 is 
constitutively expressed in most tissues and plays an important role 
in homeostasis. In particular, it is implicated in maintaining the 
protective lining of the stomach mucosa, regulating the renal blood 
flow and mediating platelet aggregation at sites of vascular injury 
(Dubois et al. 1998). By contrast, COX-2 is absent from most 
normal tissues, except for some specific regions in the brain, kidney 
and uterus. COX-2 expression is rapidly induced by inflammatory 
cytokines such as Tumor Necrosis Factor (TNF) and Interleukin (IL) 
-1 or -6 in leukocytes. Numerous oncogenic mutations in many 
genes, including c-src, Ras, APC, p53 and STK11/Lkb1, also 
stimulate COX-2 transcription. Increased amounts of COX-2 are 
found commonly in both precancerous and cancerous 
tissues(Christopher S Williams et al. 1999; Tsuji et al. 2001). 
Furthermore, COX-2 has been shown to be induced in response to 
chemotherapy and radiotherapy(Steinauer et al. 2000; Subbaramaiah 
et al. 2000). This increase in COX-2 expression results in enhanced 
synthesis of PGs in neoplasic and inflamed tissues (Dubois et al. 
1998; Subbaramaiah and Dannenberg 2003). COX-2 expression has 
been documented in most human cancers (Koki et al. 2002). Tumor 
cells, activated stromal fibroblasts, tumor infiltrating inflammatory 
cells and angiogenic endothelial cells can also express COX-2 
(Masferrer et al. 2000). 
 
Encouraged by these wide varieties of piperine applications and as  
part of their continuing program to discover COX inhibitory 
compounds from Indian medicinal plants as reported by the authors 
previously using curcumin (Girija et al. 2010) against COX-2 In the 
present study, intermolecular interactions of piperine and its 
possible mode of biological interaction with COX enzymes were 
attempted. Docking methodologies were used to test the bioactivity 
of piperine with COX enzymes. In addition, ligands known to bind 
COX enzymes were also used to establish relationships between 
their biological activity and predicted binding affinity. 
 
Materials and Methods  
Single	Crystal	X‐ray	Diffraction	Studies	of	Piperine	
 
Single crystal with dimensions of (0.38 × 0.30 × 0.15) mm3 was 
chosen for X-ray   diffraction studies. The X-ray diffraction data 
were collected on a Bruker Smart CCD Area Detector System, at 
IISc, Bangalore, using MoKa (0.71073 Å) radiation. The structure 
was solved by direct methods and difference Fourier synthesis using 
SHELXS97(Sheldrick 1997). The positions of all non-hydrogen 
atoms were included in the full-matrix least-square refinement using 
SHELXL97(Sheldrick 1997). The hydrogen atoms were fixed 
geometrically and allowed to ride on their parent C atoms and 
refined isotropically. Molecular diagrams were generated using 
ORTEP(Farrugia 1997). The C-H bond lengths are in the range of   
0.94(2)-1.04(3) Å.  The experimental conditions, crystal data and 
structure refinement results are summarized in (Table 1); the atomic 
coordinates and equivalent isotropic displacement parameters are 
listed in (Supplementary 1); selected bond lengths and angles are 
given in (Supplementary 2). The intermolecular hydrogen bonds 
including the weak interactions are listed in (Supplementary 3). 
 
Table1. Crystallographic details 
Empirical Formula                  C17 H19 N O3 
Formula weight 285.33 
Temperature 273(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic,  P21/n 
   
Unit cell dimensions a = 8.722(2)Å      
 b = 13.397(3)Å   
 c = 12.905(3) Å   
  β = 107.449(4)°. 
Volume 1438.7(6) Å3 
Z, Calculated density 4,1.317 Mg/m3 
Absorption coefficient 0.090 mm-1 
F(000) 608 
Crystal size 0.3 x 0.2 x 0.1 mm 
Theta range for data 
collection 2.25 to 24.71°. 
Limiting indices -10<=h<=10, -15<=k<=14, -15<=l<=11 
Reflections collected / 
unique 7143 / 2447 [R(int) = 0.0432] 
Completeness to theta = 
24.71 99.9 % 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2447 / 0 / 267 
Goodness-of-fit on F^2 1.108 
Final R indices [I>2sigma(I)] R1 = 0.0522, wR2 = 0.1035 
R indices (all data) R1 = 0.0740, wR2 = 0.1108 
Extinction coefficient  0.0013(12) 
Largest diff. peak and hole       0.210 and -0.183 e.Å-3
 
Molecular	Docking	Studies	
 
Molecular docking simulation of Piperine to COX-1 and COX-2 
were performed in order to gain functional and structural insight 
into the mechanism of inhibition. AutoDock 4.0(Morris et al. 1998) 
suite was used as molecular-docking tool. 
 
Protein	and	ligand	structure	preparation	
 
X-Ray Crystallographic structures of the 2.6Å model of ovine COX-
1 complexed with Ibuprofen (PDB: 1EQG) and Crystal structure of 
arachidonic acid (ACD) bound to the cyclooxygenase active site of 
COX-2 (PDB: 1CVU) were obtained from the protein databank 
(www.pdb.org). COX-2 structures (PDB: 1CVU, 1CX2 and 1PXX) 
have minor differences in their structures (sequence identity >99.5 
and RMSD<0.507 Å) (Maldonado-Rojas and Olivero-Verbel). In 
the present study 1CVU was used as the structure was solved at high 
resolution of 2.4 Å as compared to other two with 3 Å and 2.90Å, 
respectively. The structures were edited by deleting all the 
HETATOMS, water molecules and co-crystallized compounds. 
Topology file and other force field parameters were generated for 
piperine using the PRODRG program (Aalten et al. 1996). Flexible 
torsions for piperine, Ibuprofen and ACD were defined using 
AUTOTORS. In the present study, the co-crystallized ligands 
(Ibuprofen and ACD for 1EQG and 1CVU, respectively) were 
redocked within the inhibitor binding site for the evaluation of the 
accuracy of AutoDock4.0. As shown in figure 4, the RMSD of 
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0.131 and 1.705 were observed between the best docked 
confirmation and crystal structures of Ibuprofen and ACD 
respectively. This convinced to perform further docking studies of 
piperine with COX family using AutoDock 4.0.The docking site for 
piperine on 1EQG and 1CVU was defined at the position of the co-
crystallized ligands by using PyRX 0.8 interface (Wolf 2009) with 
grid box size of 61x50x55, spacing of 0.375, grid centre 25.290, 
32.999 and 201.736 for 1EQG and 27.588, 23.209 and 46.329 for 
1CVU and assigning 3 Degrees of Freedom. The Lamarckian 
Genetic Algorithm (LGA) (Morris et al. 1998) was employed with 
the population size of 150 individuals, maximum number of 
generations and energy evaluations of 27,000 and 2.5 million 
respectively. From the estimated free energy of ligand binding (∆G), 
the inhibition constant (Ki) for each ligand was calculated. Only the 
best pose (the one with the lowest binding energy) was considered 
for each ligand. The best confirmation was analyzed for proteins-
piperine interaction using Ligplot+ (Wallace et al. 1995). PyMOL 
(DeLano 2002) was used for docking confirmation representation. 
 
Results and Discussions 
 
Crystal	Structure	Analysis		
 
The determination of the crystal and molecular structure of (E,E)-1-
[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadieny piperidine 
[C17H19O3N] has been performed at 100(2) K to accurately 
determine the position of hydrogen atoms along with the associated 
supramolecular features. The precision of the structure is 
significantly improved in this new study. It belongs to the space 
group P21/n with cell parameters a = 8.7223(2), b = 13.3974(2), c = 
12.9054(3) Å and β = 107.45(3)°.  The piperine molecule is entirely 
planar and the piperidine ring assumes a chair conformation. This 
allows the bond to rotate and have 3 degrees of freedom between 
C1-C2, C4-C3, C5-C51 which in turn has a flexible interaction with 
COX enzymes. The packing of the molecule is stabilized by 
synergistic interplay of C-H...O and C-H...π intermolecular 
interactions in the crystal lattice. These noncovalent interactions not 
only structurally stabilize the compound but also allow predicting 
the probable Hydrogen bond formation between the piperine  and 
the active site residues of protein (K. Ramanathan et al. 2011). 
 
Previous report on the determination of the crystal structure (Nethaji 
and Vasantha 1989) of piperine has highlighted only the significant 
conformational features of this molecule but not packing features. 
All the crystallographic studies on piperine have been performed at 
room temperature. We have performed a determination of the 
molecular and crystal structure at 100(2)K in order to gain better 
insights into the structure and especially weak interactions. 
Subsequent analysis of the crystal packing reveals the importance of 
intermolecular interactions, which play a pivotal role in the crystal 
engineering of these molecules. A view of (1) with the atom 
labeling scheme is given in (Fig.2) 
 
Figure 2: ORTEP diagram of the title compound with 50% ellipsoidal 
probability 
 
All the bond lengths and bond angles are normal (Table 3) and the 
molecule is essentially planar. N-Substituted piperidines have been 
the subject of several X-ray crystallographic investigations and most 
of them were found to adopt a nearly planar conformation (that is 
with the N- C = O group lying in the mean plane of the piperidyl 
ring). Such a conformation would not be preferred in terms of 
nonbonded interactions alone and is to be ascribed to restricted 
rotation of freedom with the COX enzymes around the N-C partial 
bond, as can be easily proved by comparing the observed N-C 
distances with those expected for a pure single bond. 
 
The piperidyl ring tends to be coplanar with the amide group owing 
to the partial double bond character of the C(7)-N(1) bond. This is 
evident from the comprehensive discussion of the C(sp2)-
N(piperidyl) bond by Gilli and Bertolasi(Gilli.G and Bertolasi.V 
1979) The piperidine ring exhibits  a perfect chair 
conformation(Cremer and Pople 1975) with puckering parameters 
QT= 0.5620(2) Å ,  = 175.47 (2)° and ψ2= 98.97(2)°.The 
asymmetry parameter for the piperidine ring ∆Cs is 0.345. There is a 
fairly large spread  in the endocyclic torsion angles at N in the 
piperidyl moiety (N- C15-C14-C13=-56.5° (3), N-C11-C12-C13= 
54.0°(3), C15-C14-C13-C12=+52.2° (3), C14-C13-C12-C11 =54.0° 
(3), C12-C11-N-C15=-59.5° (2), C14-C15-N-C11=61.2° (2). This 
variation in the values of torsion angles are attributed to the packing 
effects. Packing effects will influence torsion angles more than bond 
angles or bond lengths. 
 
Intermolecular Interactions 
 
The packing of molecules is essentially via the involvement of weak 
intermolecular contacts.  C-H...O hydrogen bonds, involving H57A 
form dimers which are linked to the other molecule by C-H...π 
dimers, involving H11B and these dimeric motifs are held by 
additional C-H...O   hydrogen bond, involving H57B to generate 
tetrameric motifs in the crystal lattice (Fig. 3). (Table-4) C57 acts as 
bifurcated donor. The C-H…O and C-H… π interactions generate 
structural motifs, which form cavities, and the potential of these 
cavities to serve as hosts in forming complexes is currently being 
explored. 
 
Figure 3: Packing of the molecule showing the tetramer formed by C-H…O 
and C-H…π Intermolecular interactions 
 
Docking	Analysis	
 
Docking affinities of piperine and cocrystallized ligands with    
COX-1 and COX-2 are depicted in Table 5. Piperine was docked 
into the active site of COX-1 surrounding by Val116, Arg120, 
Leu352, Val349, Tyr355, Phe381, Leu384, Tyr385, Trp387, 
Phe518, Ile523, Gly526, Ala527, Ser530, Leu531 (figure 5a) and 
with COX-2 residues Phe205, Val344,Tyr348, Val349, Leu352, 
Ser353, Phe381,Tyr385, Trp387, Phe518, Met522, Val523, Ala527, 
Ser530, Leu534 as illustrated in (figure 6a). 
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The least energy confirmation from the docking of piperine into the 
active site of COX-1 is similar to that of crystallographic ligand 
Ibuprofen. The conformation with the least binding energy, having 
maximum cluster size at the active site of the respective protein was 
considered for interaction studies. Oxygen at the second position of 
methylene dioxy phenyl ring hydrogen bonded to Tyr355 (A) with 
bond distance of 2.74Å (O-H...O) and 3.05 Å (N-H…O) with 
Arg120 (A) as evident by the ligplot diagram 5b. Similar hydrogen 
bond formation can also be observed with Ibuprofen (not shown in 
figure). Formation of such hydrogen bonds contributes significantly 
to interact piperine with COX-1 at the active site. The inhibition 
constant value (Ki) of piperine is much smaller of 227.73nM than 
the Ibuprofen 855.46nM. 
 
Table 5: Molecular interaction of piperine and co-crystallized compounds 
with COX-1 and COX-2. 
 
 
Target 
protein
s 
 
Compound IC BLP HBL Interacting residues 
COX-1 
(1EQG) 
 
 
Ibuprofen 
 
855.4 -8.28 
2.96 
2.71 
2.76 
Arg120(A) 
Arg120(A) 
Tyr355(A) 
 
Piperine 227.7 -9.06 
3.05 
2.74 
Arg120(A) 
Tyr355(A) 
COX-2 
(1CVU) 
arachidonic 
acid (ACD) 82760 -5.57 - - 
Piperine 375.06 -8.77 - - 
IC- Inhibition Constant(Ki)(nM); BLP: Best ligand pose energy (Kcal/mol) 
HBL: Hydrogen bond length (A˚) 
 
Interaction of piperine with the active site of COX-2 was 
hydrophobic, which is similar to crystallographic bound substrate 
Arachidonic Acid as evident by the ligplot diagram 6b. Binding 
energy of -8.77 Kcal/mol and very low inhibition constant (Ki) of 
375.06nM was observed for piperine as compared to ACD of -
5.57Kcal/Mol and 82760nM. 
 
 
Figure 5: Interaction studies of piperine and Ibuprofen with COX-1. a) 
Interaction of piperine (blue) and ibuprofen (green) at binding site of COX-1 
as shown using PyMOL. b) Ligplot+ representation of interaction of piperine 
with COX-1. Residues represented in Ligplot+ are labeled and shown in 
PyMOL as sticks and molecular surface. Hydrogen bonds are represented by 
lines in PyMOL (a) and dashed lines in Ligplot+ (b) 
 
Conclusion 
 
Although piperine is used worldwide, in the present study its 
topological analysis of weak and strong noncovalent interactions 
using crystallographic method is performed and further extrapolated 
to molecular docking analysis to know the structure-activity 
relationship. From the analysis it was elucidated that piperine can 
inhibit the activity of both COX-1 and COX-2 enzymes, hence co-
crystallisation of piperine with COX family can be taken up for 
further design of novel class of compounds in treatment of 
biosynthesis of prostaglandin release. 
 
Figure 6: Interaction studies of piperine and Arachidonic Acid (ACD) with 
COX-2. a) Interaction of piperine (blue) and ACD (green) at binding site of 
COX-2 as shown using PyMOL.b) Ligplot+ representation of interaction of 
piperine with COX-2. Residues represented in Ligplot+ are labeled and 
shown in PyMOL as sticks and molecular surface 
 
Supplementary data are available from the CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK on request, by quoting the deposition 
number (288124) for (E, E)-1-[5-(1, 3-benzodioxol-5-yl)-1-oxo-2, 
4-pentadienyl] Piperidine (Piperine) 
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Supplementary 1. 
Atomic coordinates ( × 104) and equivalent isotropic displacement parameters 
(Å2 × 103) of NDA. 
Ueq = (1/3)ΣiΣjUij(ai*aj*)(ai.aj) 
Atom x y z U(eq) 
O(2) 1609(2) 3668(1) -3480(1) 26(1) 
O(1) 11832(2) 4523(1) 3465(1) 28(1) 
C(55) 3770(2) 4410(1) -2307(2) 19(1) 
C(56) 5086(3) 4498(2) -1423(2) 21(1) 
O(3) 3100(2) 5132(1) -3068(1) 27(1) 
C(5) 6970(3) 3677(2) 220(2) 21(1) 
C(54) 2887(2) 3541(2) -2552(2) 20(1) 
C(2) 10332(3) 5242(2) 1801(2) 22(1) 
N(1) 12634(2) 6052(1) 3082(1) 23(1) 
C(51) 5559(2) 3651(1) -746(2) 19(1) 
C(1) 11644(2) 5250(2) 2841(2) 21(1) 
C(4) 8011(3) 4432(2) 521(2) 21(1) 
C(53) 3290(3) 2705(2) -1914(2) 22(1) 
C(3) 9329(2) 4473(2) 1509(2) 21(1) 
C(52) 4648(2) 2777(2) -1010(2) 21(1) 
C(15) 13899(3) 6073(2) 4126(2) 29(1) 
C(11) 12358(3) 7037(2) 2566(2) 26(1) 
C(12) 11868(3) 7779(2) 3298(2) 32(1) 
C(13) 13074(3) 7805(2) 4423(2) 36(1) 
C(57) 1769(3) 4665(2) -3854(2) 25(1) 
C(14) 13430(3) 6763(2) 4908(2) 32(1) 
 
Supplementary 2. 
Bond lengths [Å] and angles [] 
O(2)-C(54) 1.381(2) 
O(2)-C(57) 1.441(2) 
O(1)-C(1) 1.242(2) 
C(55)-C(56) 1.359(3) 
C(55)-O(3) 1.377(2) 
C(55)-C(54) 1.380(3) 
C(56)-C(51) 1.416(3) 
O(3)-C(57) 1.436(3) 
C(5)-C(4) 1.337(3) 
C(5)-C(51) 1.466(3) 
C(54)-C(53) 1.372(3) 
C(2)-C(3) 1.331(3) 
C(2)-C(1) 1.480(3) 
N(1)-C(1) 1.354(3) 
N(1)-C(15) 1.464(3) 
N(1)-C(11) 1.466(3) 
C(51)-C(52) 1.398(3) 
C(4)-C(3) 1.439(3) 
C(53)-C(52) 1.394(3) 
C(15)-C(14) 1.511(3) 
C(11)-C(12) 1.518(3) 
C(12)-C(13) 1.517(4) 
C(13)-C(14) 1.523(3) 
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Angles 
C(54)-O(2)-C(57) 105.73(15) 
C(56)-C(55)-O(3) 127.52(18) 
C(56)-C(55)-C(54) 122.57(19) 
O(3)-C(55)-C(54) 109.91(18) 
C(55)-C(56)-C(51) 117.69(19) 
C(55)-O(3)-C(57) 106.18(15) 
C(4)-C(5)-C(51) 126.1(2) 
C(53)-C(54)-C(55) 121.8(2) 
C(53)-C(54)-O(2) 128.07(19) 
C(55)-C(54)-O(2) 110.15(17) 
C(3)-C(2)-C(1) 121.7(2) 
C(1)-N(1)-C(15) 118.63(18) 
C(1)-N(1)-C(11) 127.15(19) 
C(15)-N(1)-C(11) 112.10(18) 
C(52)-C(51)-C(56) 118.8(2) 
C(52)-C(51)-C(5) 119.85(18) 
C(56)-C(51)-C(5) 121.35(19) 
O(1)-C(1)-N(1) 121.5(2) 
O(1)-C(1)-C(2) 119.85(19) 
N(1)-C(1)-C(2) 118.66(19) 
C(5)-C(4)-C(3) 125.4(2) 
C(54)-C(53)-C(52) 116.5(2) 
C(2)-C(3)-C(4) 124.2(2) 
C(53)-C(52)-C(51) 122.69(19) 
N(1)-C(15)-C(14) 110.27(19) 
N(1)-C(11)-C(12) 110.21(18) 
C(13)-C(12)-C(11) 111.5(2) 
C(12)-C(13)-C(14) 111.7(2) 
O(3)-C(57)-O(2) 107.82(16) 
C(15)-C(14)-C(13) 110.4(2) 
 
Supplementary 3 
Nonbonded interactions and possible hydrogen bonds (Ǻ). 
(D-donor; A-acceptor; H-hydrogen) 
D—H· · ·A D—H H· · ·A D· · ·A D—H· · ·A 
C57–H57A· 
· ·O1i 
C57-H57B· · 
·O2ii 
C13-H13B· · 
·Cg3iii 
C17-H17A· · 
·Cg1iii 
1.00(2) 
0.99 (2) 
2.55(3) 
2.51(2) 
2.7919(2) 
2.8395 (2) 
3.499(3) 
3.482(3) 
3.629(2) 
3.721(2) 
158.1(2) 
167.6(2) 
137.92(3) 
141.69)3) 
 
Symmetry code: (i) – x+1,-y+1, -z   (ii)   x-1, +y, +z-1  (iii) 1-x , -y, 1-z 
 
